Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $23.87 million. The enterprise value is -$177.88 million.

Market Cap	23.87M
Enterprise Value	-177.88M

Important Dates

The last earnings date was Friday, May 15, 2026, before market open.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

SNSE has 1.34 million shares outstanding. The number of shares has increased by 0.96% in one year.

Current Share Class	1.34M
Shares Outstanding	1.34M
Shares Change (YoY)	+0.96%
Shares Change (QoQ)	+2.67%
Owned by Insiders (%)	2.09%
Owned by Institutions (%)	44.58%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.39

Current Ratio	14.39
Quick Ratio	14.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5,801.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-95.24%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-97.10%
Weighted Average Cost of Capital (WACC)	3.21%
Revenue Per Employee	n/a
Profits Per Employee	-$6.36M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +181.07% in the last 52 weeks. The beta is -0.18, so SNSE's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	+181.07%
50-Day Moving Average	27.53
200-Day Moving Average	15.72
Relative Strength Index (RSI)	28.97
Average Volume (20 Days)	32,611

Short Selling Information

The latest short interest is 834,411, so 62.18% of the outstanding shares have been sold short.

Short Interest	834,411
Short Previous Month	855,820
Short % of Shares Out	62.18%
Short % of Float	n/a
Short Ratio (days to cover)	19.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-185.64M
Pretax Income	-184.46M
Net Income	-184.46M
EBITDA	-185.51M
EBIT	-185.64M
Earnings Per Share (EPS)	-$145.28

Balance Sheet

The company has $202.79 million in cash and $1.04 million in debt, with a net cash position of $201.75 million or $150.34 per share.

Cash & Cash Equivalents	202.79M
Total Debt	1.04M
Net Cash	201.75M
Net Cash Per Share	$150.34
Equity (Book Value)	-137.29M
Book Value Per Share	-102.43
Working Capital	190.04M

Cash Flow

In the last 12 months, operating cash flow was -$24.09 million and capital expenditures -$22,000, giving a free cash flow of -$24.11 million.

Operating Cash Flow	-24.09M
Capital Expenditures	-22,000
Depreciation & Amortization	135,000
Net Borrowing	-641,000
Free Cash Flow	-24.11M
FCF Per Share	-$17.97

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.96%
Shareholder Yield	-0.96%
Earnings Yield	-772.66%
FCF Yield	-101.01%

Analyst Forecast

The average price target for SNSE is $50.00, which is 177.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$50.00
Price Target Difference	177.78%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2